Cookies on this site

A grant from the National Institute for Health and Care Research (NIHR) is funding a study to improve healthcare treatment and care for patients with broken bones in three Sub-Saharan Africa countries.

Man on crutches © Shutterstock

Injuries are the leading cause of death in people aged between 10-49 years and are responsible for more deaths than from HIV, malaria, and tuberculosis combined. For every person who dies, up to 50 people survive but become disabled. Broken bones account for most of these injuries, and disproportionally affect people living in poor regions, such as countries in Africa.

A team from NDORMS, led by Simon Graham, Associate Professor of Orthopaedic Trauma Surgery has been awarded a grant from the National Institute for Health and Care Research (NIHR) to find out more and see what can be done to improve treatment and outcomes for the injured. Focussing on three Sub-Saharan Africa (SSA) countries (Malawi, Tanzania and South Africa) Simon and the team will explore how many individuals sustain a broken bone, what healthcare services are available to treat them, how the injury affects individuals and their families and ways to improve their recovery.

Simon said: ‘Musculoskeletal injuries such as broken bones create a huge burden on healthcare systems across the world but despite this there is little evidence to guide the management of such injuries in low- and middle- income countries (LMICs). Sub-Saharan Africa has a higher incidence of MSK injuries than any other world region so our research will not only support the care of injuries in this area but provide a lasting legacy to drive improved care across LMICs as a whole.’

The project has four themes;

1.     CAPACITY: Healthcare workers have limited research training and resources, hindering improvements in patient care for broken bones. The study will assess current research capabilities and develop educational resources to address these gaps.

2.     MAPPING: The team will establish a network of hospitals in partner countries to study the incidence of five specific broken bones identified by the WHO and assess the resources available for treatment.

  1. OUTCOMES: The study will examine how patients recover from their injury and the impact on their lives and livelihoods for each of the five types of broken bones.
  2. CHANGE: A multi-centre study through the network of collaborating hospitals, will 'test' the feasibility of large-scale research studies.

‘We are grateful to the NIHR for supporting our research that will enable us to work towards our vision that the care for broken bones in a low resource setting can be safe, accessible, and appropriate to the local healthcare systems,’ Simon added.

Similar stories

Professor Menna Clatworthy to join the Kennedy Institute at NDORMS

Professor Menna Clatworthy, recently announced as the new Regius Professor of Medicine at the University of Oxford, will join the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) as a Principal Investigator at the Kennedy Institute of Rheumatology with effect from March 2027. Professor Clatworthy will also join the Nuffield Department of Surgical Sciences highlighting the breadth and relevance of her research to multiple medical departments in Oxford.

Could patients with common fractures recover without routine hospital follow-up?

The FASTER study will investigate whether thousands of people with common fractures can recover just as well with good-quality advice and rehabilitation guidance, without the need for routine hospital follow-up appointments.

Could the gut’s nervous system hold new clues to treating Crohn’s disease?

Researchers at the Kennedy Institute are investigating whether the nervous system within the gut could provide a new way to understand and ultimately treat Crohn’s disease.

NDORMS appoints a new Research Professor of Regulatory Innovation to help accelerate the development pipeline of new treatments

Lincoln Tsang has been appointed as the new John Climax Research Professor of Regulatory Innovation – a new role at NDORMS and the University of Oxford that brings global regulatory and legal expertise to our ambitions to transform and improve drug development pathways in order to help deliver safe and effective treatments to patients sooner. He will assume this role effective 2 January 2027.

Look Beyond My Skin: Your Psoriasis Could Help Us Understand Who Develops Psoriatic Arthritis

Adults with psoriasis across Europe are invited to take part in an online study aiming to identify who is at risk of developing psoriatic arthritis.

New PI Marie Pust aims to bring microbiome research closer to patients

We welcome Marie-Madlen Pust, who has joined the Kennedy Institute as a new Principal Investigator. Marie will establish a research group combining computational biology with targeted experimental microbiology to identify microbial drivers of chronic inflammatory disease that can be monitored (diagnostic potential) or modified (therapeutic potential).